Registration number:
Unaudited Abbreviated Accounts
for the Year Ended
Oxbridge Pharma Limited
Contents
|
|||
|
Oxbridge Pharma Limited
(Registration number: 04527162)
Abbreviated Balance Sheet at 30 September 2014
Note |
2014
|
(As restated)
|
|||||||
Fixed assets |
|||||||||
Tangible fixed assets |
|
|
|||||||
Current assets |
|||||||||
Debtors |
|
|
|||||||
Cash at bank and in hand |
|
|
|||||||
|
|
||||||||
Creditors: Amounts falling due within one year |
( |
( |
|||||||
Net current liabilities |
( |
( |
|||||||
Net liabilities |
( |
( |
|||||||
Capital and reserves |
|||||||||
Called up share capital |
|
|
|||||||
Profit and loss account |
( |
( |
|||||||
Shareholders' deficit |
( |
( |
Approved by the Board on
J Ha
Director
1
Oxbridge Pharma Limited
Notes to the Abbreviated Accounts for the Year Ended 30 September 2014
......... continued
Accounting policies |
Basis of preparation
Going concern
The balance sheet is in deficit at the year end. The Directors believe a major supplier will continue to provide funding to the company and steps have been made since the year to make significant improvements to the trading position. Based on this the Directors believe the company to be considered a going concern
Turnover
Depreciation
Depreciation is provided on tangible fixed assets so as to write off the cost or valuation, less any estimated
residual value, over their expected useful economic life as follows:
Asset class |
Depreciation method and rate |
Office equipment |
|
Foreign currency
Hire purchase and leasing
Financial instruments
Oxbridge Pharma Limited
Notes to the Abbreviated Accounts for the Year Ended 30 September 2014
......... continued
Fixed assets |
Tangible assets
|
Total
|
|||||
Cost |
||||||
At 1 October 2013 |
9,089 |
9,089 |
||||
At 30 September 2014 |
9,089 |
9,089 |
||||
Depreciation |
||||||
At 1 October 2013 |
6,486 |
6,486 |
||||
Charge for the year |
943 |
943 |
||||
At 30 September 2014 |
7,429 |
7,429 |
||||
Net book value |
||||||
At 30 September 2014 |
|
|
||||
At 30 September 2013 |
|
|
Share capital |
Allotted, called up and fully paid shares
2014 |
2013 |
|||||||||||
No. |
£ |
No. |
£ |
|||||||||
|
|
|
|
|
||||||||
Prior period adjustments |
Control |
The company is controlled by